1-13 of 13
Geir E Tjønnfjord
Close
Sort by
Journal Articles

NNV024, a Humanized Anti-CD37 Antibody with Enhanced ADCC and Extended Plasma Half-Life for the Treatment of B-Cell Malignancies

Roman Generalov, Elisa Fiorito, Stian Foss, Veronique Pascal, Helen Heyerdahl, Ada Repetto-Llamazares, Jan Terje Andersen, Geir E Tjønnfjord, Sigrid Strand Skånland, Jostein Dahle
Journal: Blood
Blood (2022) 140 (Supplement 1): 3123–3124.
https://doi.org/10.1182/blood-2022-166275
Published: 2022
Journal Articles

B-Cell Targeting Anti-CD37 Humanized Antibodies Engineered for Potent Effector Functions and Extended Plasma Half-Life

Elisa Fiorito, Roman Generalov, Stian Foss, Helen Heyerdahl, Ada Repetto-Llamazares, Veronique Pascal, Geir E Tjønnfjord, Sigrid Strand Skånland, Jan Terje Andersen, Jostein Dahle
Journal: Blood
Blood (2022) 140 (Supplement 1): 6012–6013.
https://doi.org/10.1182/blood-2022-159382
Published: 2022
Journal Articles

Gene Expression Analysis Reveals Downregulation of Complement Receptor 1 in Cold Agglutinin Disease

Agnieszka Malecka, Ingunn Ostlie, Gunhild Trøen, Jędrzej M. Małecki, Jan Delabie, Anne Tierens, Sigbjørn Berentsen, Geir E Tjønnfjord
Journal: Blood
Blood (2022) 140 (Supplement 1): 6419–6420.
https://doi.org/10.1182/blood-2022-156489
Published: 2022
Journal Articles

Role of Extracorporeal Photopheresis in Prevention of Graft-Versus-Host Disease in Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation: A Randomized Controlled Trial

Maryan M Ali, Tobias Gedde-Dahl, Marit B Veierød, Geir E Tjønnfjord, Per Ole Iversen
Journal: Blood
Blood (2021) 138 (Supplement 1): 102.
https://doi.org/10.1182/blood-2021-147243
Published: 2021
Journal Articles

Cold agglutinin disease revisited: a multinational, observational study of 232 patients

Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, Ulla Randen, Tor Henrik Anderson Tvedt, Bruno Fattizzo, Einar Haukås, Megan Kell, Robert Brudevold, Anders E. A. Dahm, Jakob Dalgaard, Hege Frøen, Randi Fykse Hallstensen, Pernille H. Jæger, Henrik Hjorth-Hansen, Agnieszka Małecka, Markku Oksman, Jürgen Rolke, Mallika Sekhar, Jon Hjalmar Sørbø, Eirik Tjønnfjord, Galina Tsykunova, Geir E. Tjønnfjord
Journal: Blood
Blood (2020) 136 (4): 480–488.
https://doi.org/10.1182/blood.2020005674
Published: 2020
Includes: Supplemental data
Journal Articles

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial

Clinical Trials & Observations
Sigbjørn Berentsen, Ulla Randen, Markku Oksman, Henrik Birgens, Tor Henrik Anderson Tvedt, Jakob Dalgaard, Eivind Galteland, Einar Haukås, Robert Brudevold, Jon Hjalmar Sørbø, Inger Anne Næss, Agnieszka Malecka, Geir E. Tjønnfjord
Journal: Blood
Blood (2017) 130 (4): 537–541.
https://doi.org/10.1182/blood-2017-04-778175
Published: 2017
Journal Articles

High Frequency of Somatic Mutations of KMT2D and CARD11 Genes in Cold Agglutinin Disease

Agnieszka Malecka, Gunhild Trøen, PhD, Anne Tierens, Ingunn Østlie, Jedrzej Malecki, PhD, Ulla Randen, MD PhD, Sigbjørn Berentsen, MD PhD, Geir E. Tjønnfjord, Jan M.A. Delabie, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2934.
https://doi.org/10.1182/blood.V128.22.2934.2934
Published: 2016
Journal Articles

No Effect of Individualized Nutrition on Quality of Life, Acute Graft-Versus-Host Disease or Oral Mucositis after Allogeneic Stem Cell Transplantation: A Randomized Controlled Trial

Kristin J. Skaarud, Marianne J. Hjermstad, Asta Bye, Marit B. Veierød, Anne M. Gudmundstuen, Knut E. A Lundin, Sonia Distante, Lorentz Brinch, Geir E. Tjønnfjord, Per O. Iversen
Journal: Blood
Blood (2016) 128 (22): 2211.
https://doi.org/10.1182/blood.V128.22.2211.2211
Published: 2016
Journal Articles

Targeting Integrin a4b7-Expressing T-Cells in Steroid Refractory Intestinal GvHD

Yngvar Floisand, MDPhD, Knut Lundin, MDPhD, Vladimir Lazarevic, MD, Jorn Dehli Kristiansen, RN, Liv T. N. Osnes, MD PhD, Geir E. Tjonnfjord, MD PhD, Henrik Mikael Reims, MDPhD, Tobias Gedde-Dahl, MDPhD
Journal: Blood
Blood (2015) 126 (23): 3137.
https://doi.org/10.1182/blood.V126.23.3137.3137
Published: 2015
Journal Articles

Rituximab As Second Line Treatment For Adult Immune Thrombocytopenia (ITP): A Multicentre, Randomized, Double Blind, Placebo-Controlled Study – The Ritp Study (NCT00344149)

Waleed Ghanima, MD, PhD, Abderrahim Khelif, Neila Benromdhan, MD, Anders Waage, MD, PhD, Geir E. Tjonnfjord, MD, PhD, Marc Michel, Darne Bernadette, MD, Johannes Kahrs, MD, Pål Andre Holme, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 449.
https://doi.org/10.1182/blood.V122.21.449.449
Published: 2013
Journal Articles

High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease

Clinical Trials & Observations
Sigbjørn Berentsen, Ulla Randen, Anne Marita Vågan, Henrik Hjorth-Hansen, Anders Vik, Jakob Dalgaard, Eva-Marie Jacobsen, Aud S. Thoresen, Klaus Beiske, Geir E. Tjønnfjord
Journal: Blood
Blood (2010) 116 (17): 3180–3184.
https://doi.org/10.1182/blood-2010-06-288647
Published: 2010
Journal Articles

Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients

Clinical Trials & Observations
Sigbjørn Berentsen, Elling Ulvestad, Bjørn Tore Gjertsen, Henrik Hjorth-Hansen, Ruth Langholm, Håvar Knutsen, Waleed Ghanima, Fuad Victor Shammas, Geir E. Tjønnfjord
Journal: Blood
Blood (2004) 103 (8): 2925–2928.
https://doi.org/10.1182/blood-2003-10-3597
Published: 2004
Journal Articles

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

Clinical Trials & Observations
Claire E. Dearden, Estella Matutes, Bruno Cazin, Geir E. Tjønnfjord, Antonio Parreira, Benet Nomdedeu, Pietro Leoni, Fiona J. Clark, Deepti Radia, Saad M. B. Rassam, Tony Roques, Nicolas Ketterer, Vasantha Brito-Babapulle, Martin J. S. Dyer, Daniel Catovsky
Journal: Blood
Blood (2001) 98 (6): 1721–1726.
https://doi.org/10.1182/blood.V98.6.1721
Published: 2001